Your browser doesn't support javascript.
loading
Preclinical activity of the repurposed drug auranofin in classical Hodgkin lymphoma.
Celegato, Marta; Borghese, Cinzia; Casagrande, Naike; Mongiat, Maurizio; Kahle, Xaver U; Paulitti, Alice; Spina, Michele; Colombatti, Alfonso; Aldinucci, Donatella.
Afiliação
  • Celegato M; Department of Experimental Oncology 2, CRO Aviano National Cancer Institute, Aviano, PN, Italy.
  • Borghese C; Department of Experimental Oncology 2, CRO Aviano National Cancer Institute, Aviano, PN, Italy.
  • Casagrande N; Department of Experimental Oncology 2, CRO Aviano National Cancer Institute, Aviano, PN, Italy.
  • Mongiat M; Department of Experimental Oncology 2, CRO Aviano National Cancer Institute, Aviano, PN, Italy.
  • Kahle XU; Department of Pathology and Medical Biology, University of Groningen, Groningen, The Netherlands.
  • Paulitti A; Department of Experimental Oncology 2, CRO Aviano National Cancer Institute, Aviano, PN, Italy.
  • Spina M; Division of Medical Oncology A, CRO Aviano National Cancer Institute, Aviano, PN, Italy.
  • Colombatti A; Department of Experimental Oncology 2, CRO Aviano National Cancer Institute, Aviano, PN, Italy.
  • Aldinucci D; Department of Experimental Oncology 2, CRO Aviano National Cancer Institute, Aviano, PN, Italy.
Blood ; 126(11): 1394-7, 2015 Sep 10.
Article em En | MEDLINE | ID: mdl-26228484

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Auranofina / Antineoplásicos Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Auranofina / Antineoplásicos Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article